Search

Your search keyword '"A. OLA ODUGBESAN"' showing total 3 results
Start Over Author "A. OLA ODUGBESAN" Search Limiters Peer Reviewed
3 results on '"A. OLA ODUGBESAN"'

1. Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease

Author

Ola Odugbesan, Kenneth S. Hershon, and Barbara R. Hirsch

Subjects
medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, MEDLINE, 030209 endocrinology & metabolism, Type 2 diabetes, Disease, medicine.disease, Feature Articles, 03 medical and health sciences, 0302 clinical medicine, Postprandial, Internal medicine, Epidemiology, Internal Medicine, medicine, sense organs, 030212 general & internal medicine, business
Abstract

IN BRIEF This article reviews the evidence regarding the impact of postprandial glucose (PPG) on overall A1C and its relation to cardiovascular disease (CVD). To date, four randomized, controlled trials have evaluated the impact of PPG reduction on CVD; however, only one of these successfully demonstrated a positive effect. Despite this, epidemiological evidence does indicate a cardiovascular benefit of PPG reduction, and agents that can be used to manage PPG in people with type 2 diabetes are also discussed.

Published
2019
Full Text
View/download PDF

2. Reduced Hypoglycemia and Comparable Efficacy with Insulin Glargine 300 U/ML Versus Insulin Glargine 100 U/ML in Patients with Type 2 Diabetes Achieving Different Levels of Prebreakfast Self-Monitored Plasma Glucose

Author

Jason Chao, Timothy S. Bailey, Ola Odugbesan, Jasvinder Gill, Elena Nikonova, and Timothy Reid

Subjects
medicine.medical_specialty, Plasma glucose, business.industry, Insulin glargine, Endocrinology, Diabetes and Metabolism, nutritional and metabolic diseases, General Medicine, Type 2 diabetes, Hypoglycemia, medicine.disease, Endocrinology, Internal medicine, Medicine, lipids (amino acids, peptides, and proteins), In patient, cardiovascular diseases, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug
Abstract

Objective: To evaluate the efficacy and safety of insulin glargine 300 U/mL (Gla-300) and insulin glargine 100 U/mL (Gla-100) in patients with type 2 diabetes (T2D) who reached prebreakfas...

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results